Test & Treat

Test & Treat was a UK private diagnostics and medical device company developing point-of-care tests for rapid detection of bacterial infections and antibiotic susceptibility, with an initial focus on urinary tract infection. Its technology used ATP bioluminescence to identify infection quickly and generate phenotypic antibiotic sensitivity information at or near the point of care. The company appears to have pursued early commercialization first in veterinary markets, especially companion animal UTI testing, while also positioning the technology for broader human clinical applications through licensing or partnership models. Public sources also indicate interest in additional applications such as mastitis, tuberculosis, and septic effusions. Although third-party databases still list the business as active, the official UK Companies House record shows TEST&TREAT LTD was dissolved on July 20, 2024.